Amneal Pharmaceuticals, Inc. Logo

Amneal Pharmaceuticals, Inc.

Develops & commercializes essential medicines: generics, injectables & specialty drugs.

AMRX | US

Overview

Corporate Details

ISIN(s):
US03168L1052
LEI:
Country:
United States of America
Address:
0
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Amneal Pharmaceuticals, Inc. is a fully-integrated global biopharmaceutical company engaged in the development, manufacturing, and commercialization of essential medicines. Its diverse portfolio features over 280 products, including generics, injectables, and specialty branded pharmaceuticals. The company operates through a robust generics business and a growing specialty division, with a strategic focus on complex medicines. Key therapeutic areas include oncology and central nervous system disorders like Parkinson's disease, complemented by public health initiatives to increase access to treatments such as Naloxone. A core competency is the development of first-to-file and first-to-market products, aiming to make quality healthcare more accessible and affordable for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Amneal Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Amneal Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Amneal Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Pharmocann Global Ltd. Logo
Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.
Israel PMCN-M
Pharvaris N.V. Logo
Developing oral therapies for rare angioedema to treat and prevent attacks.
United States of America PHVS
Phathom Pharmaceuticals, Inc. Logo
Develops and commercializes treatments for acid-related gastrointestinal diseases.
United States of America PHAT
Pherecydes Pharma Logo
Develops precision phage therapy to treat resistant bacterial infections.
France ALPHE
PHIBRO ANIMAL HEALTH CORP Logo
Develops animal health products, vaccines, and nutrition for livestock and companion animals.
United States of America PAHC
Philogen Logo
Developing targeted biopharmaceuticals for oncology using proprietary ligand-based delivery.
Italy PHIL
Phio Pharmaceuticals Corp. Logo
Developing RNAi-based immuno-oncology therapeutics for melanoma and other skin cancers.
United States of America PHIO
Phoenix Asia Holdings Ltd Logo
A subcontractor for substructure projects and a large-scale manufacturer of fine chemicals & APIs.
United States of America PHOE
Photocure ASA Logo
Develops photodynamic pharmaceuticals and devices to enhance bladder cancer detection for urologists.
Norway PHO
Pierrel Logo
Global pharma company specializing in dental anesthetics and contract manufacturing services.
Italy PRL

Talk to a Data Expert

Have a question? We'll get back to you promptly.